Short Description The FDA Q-Submission Program is an important regulatory pathway that helps Medical Device sponsors reduce potential risks before submitting a formal application. By obtaining early FDA feedback, sponsors can clarify...

Short Description The FDA Q-Submission Program is a voluntary process that allows Medical Device developers to communicate with the United States Food and Drug Administration before submitting a formal regulatory application. It...

A marketing authorization holder (MAH) plays a critical role in ensuring that medicinal products marketed in the European Union (EU) continue to meet Regulatory standards for quality, safety, and efficacy throughout their...

GDUFA self-identification is a mandatory FDA compliance process for generic Drug facilities and related sites. It supports FDA self-identification (Generic Drugs) by mandating structured annual submissions. The process ensures transparency, supports regulatory...

The National Drug Code or NDC system works as a structured method for identifying Drug products in the United States. It describes the format, assignment process, and regulatory requirements for companies that...